BOONE — A research team at Appalachian State University is investigating effective treatments for one of the most aggressive types of breast cancer — with the goal of reducing adverse side effects.

Michael Reddish, assistant professor in App State’s A.R. Smith Department of Chemistry and Fermentation Sciences, has been awarded a grant from the North Carolina Biotechnology Center to study medications proposed to treat triple-negative breast cancers, which he said have “the least number of and least effective treatment options available.”

Trending Recipes



Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.